Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I)

Zhongda Hospital20,000 enrolled

Overview

Evaluation of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population

Using the WHO criteria as the golden standard，drawing the ROC curve of 2h-UG combined with FPG, AGEsP alone or in combination with FPG，calculating the area under the ROC curve.

Study Type

OBSERVATIONAL

Enrollment

20,000

Conditions

Type II Diabetes Mellitus

Eligibility

Sex: ALLMin age: 12 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 20\~70 year old urban and rural residents; * Volunteer to participate in this study and sign informed consent. Exclusion Criteria: \-

Locations (1)

Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Southeast University

Nanjing, Jiangsu, China

RECRUITING

Outcomes

Primary Outcomes

area under the ROC curve

area under the ROC curve of different method of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population

Time frame: 6 months

Secondary Outcomes

sensitivity and specificity of screening

Using WHO criteria as golden standard,sensitivity and specificity of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.